Table 1.
Demographic data of all first nonhypoxic status epilepticus episodes in adults
| All episodes of first SE (women N, %) | 221 (124, 56.0) |
| Age (y), median (IQR) | 69 (28) |
| Onset in hospital, N (%) | 58 (26.2) |
| History of epilepsy, N (%) | 90 (40.7) |
| Witnessed onset, N (%) | 101 (45.7) |
| Types of etiology, N (%) | |
| Symptomatic | 217 (98.2) |
| Acute | 80 (36.2) |
| Remote | 103 (46.6) |
| Progressive | 31 (14.0) |
| SE defined in electroclinical syndromes | 3 (1.4) |
| Cryptogenic (unknown) | 4 (1.8) |
| Etiology, N (%) | |
| Cerebrovascular | 100 (45.2) |
| Trauma | 37 (16.7) |
| Metabolic | 25 (11.3) |
| Tumors | 23 (10.4) |
| Toxic | 8 (3.6) |
| Degenerative disorders | 7 (3.2) |
| Infectious | 4 (1.8) |
| Immune‐mediated | 4 (1.8) |
| Others | 15 (6.8) |
| RSE episodes, N (%)/case fatality, % | 45 (20.4)/39.5 |
| RSE treated with a second or more AED, but no anesthetics | 41 (18.6)/41.5 |
| RSE treated with anesthetics | 4 (1.8)/25.0 |
| SRSE episodes, N (%)/case fatality, % | 8 (3.6)/37.5 |
Types of etiology are classified according to ILAE 2015. IQR, interquartile range; RSE, refractory status epilepticus; SE, status epilepticus; SRSE, super‐refractory status epilepticus.